We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Clinical Trial Assesses Anti-clotting Drug for Treatment of COVID-19-related Respiratory Failure

News   Apr 07, 2020 | Original story from Beth Israel Deaconess Medical Center

 
Clinical Trial Assesses Anti-clotting Drug for Treatment of COVID-19-related Respiratory Failure
 
 
Advertisement
 

RELATED ARTICLES

Mother's Microbiota "Educates" Their Offspring's Immune System

News

New research on the development of the immune system during infancy has shown that there is a causal relationship between neonatal antibody production and the mother's microbiota.

READ MORE

New Study Explores Association Between SARS-CoV-2 and Blood Group A

News

A new study by researchers at Brigham and Women's Hospital adds to the body of work exploring blood group and COVID-19 susceptibility and severity.

READ MORE

Novel Form of Microbial Symbiosis Discovered

News

Up until now it was assumed that only mitochondria can take over the task of providing energy in cells. But scientists have now discovered that this is not the case. An energy-providing bacterial endosymbiont has been found that enables its unicellular eukaryotic host to breathe nitrate.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Biopharma Immunology & Microbiology

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE